Completed PHASE4 INTERVENTIONAL 2-arm NCT01751256

Additional Effect of Wound Infiltration After Cesarean Section With Optimal Standard Analgesia (KTcesar)

Levobupivacaine Continuous Wound Infiltration and Optimal Standard Analgesia Versus Optimal Standard Analgesia Alone After Cesarean Section.

Sponsor: Poissy-Saint Germain Hospital

Conditions Anesthesia, Local Breast Feeding Postoperative Pain

Interventions Continuous wound infiltration

Updated 5 times since 2017 Last updated: Dec 14, 2012 Started: Jun 30, 2010 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Anesthesia, Local and Breast Feeding and is currently completed. Poissy-Saint Germain Hospital leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Poissy-Saint Germain Hospital

Data source: Poissy-Saint Germain Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Poissy, France